ID   AL1A1_RAT               Reviewed;         501 AA.
AC   P51647; O09184;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 167.
DE   RecName: Full=Aldehyde dehydrogenase 1A1 {ECO:0000305|PubMed:7832787};
DE            EC=1.2.1.19 {ECO:0000250|UniProtKB:P24549};
DE            EC=1.2.1.28 {ECO:0000250|UniProtKB:P00352};
DE            EC=1.2.1.3 {ECO:0000269|PubMed:7832787};
DE            EC=1.2.1.36 {ECO:0000269|PubMed:7832787};
DE   AltName: Full=3-deoxyglucosone dehydrogenase {ECO:0000250|UniProtKB:P00352};
DE   AltName: Full=ALDH-E1;
DE   AltName: Full=ALHDII;
DE   AltName: Full=Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|RGD:2087};
DE   AltName: Full=Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:8543180};
DE   AltName: Full=Retinal dehydrogenase 1 {ECO:0000305};
DE            Short=RALDH 1 {ECO:0000303|PubMed:9218716};
DE            Short=RalDH1 {ECO:0000303|PubMed:9218716};
GN   Name=Aldh1a1 {ECO:0000312|RGD:2087};
GN   Synonyms=Aldh {ECO:0000303|PubMed:8543180};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8543180; DOI=10.1016/0378-1119(96)81752-5;
RA   Bhat P.V., Labrecque J., Boutin J.-M., Lacroix A., Yoshida A.;
RT   "Cloning of a cDNA encoding rat aldehyde dehydrogenase with high activity
RT   for retinal oxidation.";
RL   Gene 166:303-306(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9059608; DOI=10.1007/978-1-4615-5871-2_9;
RA   Kathmann E.C., Lipsky J.J.;
RT   "A preliminary report on the cloning of a constitutively expressed rat
RT   liver cytosolic ALDH cDNA by PCR.";
RL   Adv. Exp. Med. Biol. 414:69-72(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9240474; DOI=10.1006/bbrc.1997.6998;
RA   Kathmann E.C., Lipsky J.J.;
RT   "Cloning of a cDNA encoding a constitutively expressed rat liver cytosolic
RT   aldehyde dehydrogenase.";
RL   Biochem. Biophys. Res. Commun. 236:527-531(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9218716; DOI=10.1016/s0378-1119(97)00054-1;
RA   Penzes P., Wang X., Sperkova Z., Napoli J.L.;
RT   "Cloning of a rat cDNA encoding retinal dehydrogenase isozyme type I and
RT   its expression in E. coli.";
RL   Gene 191:167-172(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19; 80-91; 96-121; 205-225; 237-258 AND 394-438,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, PATHWAY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=7832787; DOI=10.1042/bj3050681;
RA   Labrecque J., Dumas F., Lacroix A., Bhat P.V.;
RT   "A novel isoenzyme of aldehyde dehydrogenase specifically involved in the
RT   biosynthesis of 9-cis and all-trans retinoic acid.";
RL   Biochem. J. 305:681-684(1995).
RN   [7]
RP   FUNCTION.
RX   PubMed=15623782; DOI=10.1167/iovs.04-0120;
RA   Choudhary S., Xiao T., Vergara L.A., Srivastava S., Nees D.,
RA   Piatigorsky J., Ansari N.H.;
RT   "Role of aldehyde dehydrogenase isozymes in the defense of rat lens and
RT   human lens epithelial cells against oxidative stress.";
RL   Invest. Ophthalmol. Vis. Sci. 46:259-267(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cytosolic dehydrogenase that catalyzes the irreversible
CC       oxidation of a wide range of aldehydes to their corresponding
CC       carboxylic acid (PubMed:15623782, PubMed:7832787). Functions downstream
CC       of retinol dehydrogenases and catalyzes the oxidation of retinaldehyde
CC       into retinoic acid, the second step in the oxidation of retinol/vitamin
CC       A into retinoic acid. This pathway is crucial to control the levels of
CC       retinol and retinoic acid, two important molecules which excess can be
CC       teratogenic and cytotoxic (PubMed:7832787). Also oxidizes aldehydes
CC       resulting from lipid peroxidation like (E)-4-hydroxynon-2-enal/HNE,
CC       malonaldehyde and hexanal that form protein adducts and are highly
CC       cytotoxic. By participating for instance to the clearance of (E)-4-
CC       hydroxynon-2-enal/HNE in the lens epithelium prevents the formation of
CC       HNE-protein adducts and lens opacification (PubMed:15623782). Functions
CC       also downstream of fructosamine-3-kinase in the fructosamine
CC       degradation pathway by catalyzing the oxidation of 3-deoxyglucosone,
CC       the carbohydrate product of fructosamine 3-phosphate decomposition,
CC       which is itself a potent glycating agent that may react with lysine and
CC       arginine side-chains of proteins (By similarity). Has also an
CC       aminobutyraldehyde dehydrogenase activity and is probably part of an
CC       alternative pathway for the biosynthesis of GABA/4-aminobutanoate in
CC       midbrain, thereby playing a role in GABAergic synaptic transmission (By
CC       similarity). {ECO:0000250|UniProtKB:P00352,
CC       ECO:0000250|UniProtKB:P24549, ECO:0000269|PubMed:15623782,
CC       ECO:0000269|PubMed:7832787}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.3; Evidence={ECO:0000269|PubMed:7832787};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16186;
CC         Evidence={ECO:0000305|PubMed:7832787};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=all-trans-retinal + H2O + NAD(+) = all-trans-retinoate + 2
CC         H(+) + NADH; Xref=Rhea:RHEA:42080, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17898, ChEBI:CHEBI:35291,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.2.1.36;
CC         Evidence={ECO:0000269|PubMed:7832787};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42081;
CC         Evidence={ECO:0000305|PubMed:7832787};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-cis-retinal + H2O + NAD(+) = 9-cis-retinoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:42084, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78273,
CC         ChEBI:CHEBI:78630; Evidence={ECO:0000269|PubMed:7832787};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42085;
CC         Evidence={ECO:0000305|PubMed:7832787};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11-cis-retinal + H2O + NAD(+) = 11-cis-retinoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:47132, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16066, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:87435; Evidence={ECO:0000269|PubMed:7832787};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47133;
CC         Evidence={ECO:0000305|PubMed:7832787};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=13-cis-retinal + H2O + NAD(+) = 13-cis-retinoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:67332, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:45487, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:169952; Evidence={ECO:0000250|UniProtKB:Q8HYE4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67333;
CC         Evidence={ECO:0000250|UniProtKB:Q8HYE4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-deoxyglucosone + H2O + NAD(+) = 2-dehydro-3-deoxy-D-
CC         gluconate + 2 H(+) + NADH; Xref=Rhea:RHEA:67244, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:57990, ChEBI:CHEBI:60777;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67245;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-4-hydroxynon-2-enal + H2O + NAD(+) = (E)-4-hydroxynon-2-
CC         enoate + 2 H(+) + NADH; Xref=Rhea:RHEA:67248, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:58968, ChEBI:CHEBI:142920;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67249;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + malonaldehyde + NAD(+) = 3-oxopropanoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:67252, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33190, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:566274; Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67253;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hexanal + NAD(+) = 2 H(+) + hexanoate + NADH;
CC         Xref=Rhea:RHEA:67276, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17120, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:88528; Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67277;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) + propanal = 2 H(+) + NADH + propanoate;
CC         Xref=Rhea:RHEA:67256, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17153, ChEBI:CHEBI:17272, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67257;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetaldehyde + H2O + NAD(+) = acetate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:25294, ChEBI:CHEBI:15343, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30089, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25295;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=benzaldehyde + H2O + NAD(+) = benzoate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:11840, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16150, ChEBI:CHEBI:17169, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.28;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11841;
CC         Evidence={ECO:0000250|UniProtKB:P00352};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-aminobutanal + H2O + NAD(+) = 4-aminobutanoate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:19105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:58264,
CC         ChEBI:CHEBI:59888; EC=1.2.1.19;
CC         Evidence={ECO:0000250|UniProtKB:P24549};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19106;
CC         Evidence={ECO:0000250|UniProtKB:P24549};
CC   -!- ACTIVITY REGULATION: Inhibited by chloral hydrate.
CC       {ECO:0000269|PubMed:7832787}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.7 uM for 9-cis retinal (at pH 7.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:7832787};
CC         KM=9.8 uM for all-trans retinal (at pH 7.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:7832787};
CC         KM=10.5 uM for 11-cis retinal (at pH 7.5 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:7832787};
CC         Note=Has more than 2-fold higher catalytic efficiency for 9-cis
CC         retinal compared to all-trans retinal and 11-cis retinal.
CC         {ECO:0000269|PubMed:7832787};
CC   -!- PATHWAY: Cofactor metabolism; retinol metabolism.
CC       {ECO:0000269|PubMed:7832787}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with PRMT3; the
CC       interaction is direct, inhibits ALDH1A1 aldehyde dehydrogenase activity
CC       and is independent of the methyltransferase activity of PRMT3 (By
CC       similarity). {ECO:0000250|UniProtKB:P00352,
CC       ECO:0000250|UniProtKB:P51977}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P00352}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:P24549}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in kidney, lung, testis,
CC       intestine, stomach, and trachea, but weakly in the liver.
CC       {ECO:0000269|PubMed:8543180}.
CC   -!- PTM: The N-terminus is blocked most probably by acetylation.
CC       {ECO:0000305|PubMed:7832787}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42009; AAA96657.1; -; mRNA.
DR   EMBL; AF001896; AAC53304.1; -; mRNA.
DR   EMBL; AF001898; AAC53306.1; -; mRNA.
DR   EMBL; AF001897; AAC53305.1; -; mRNA.
DR   EMBL; U79118; AAB63423.1; -; mRNA.
DR   EMBL; BC061526; AAH61526.1; -; mRNA.
DR   PIR; JC4524; JC4524.
DR   PIR; JC5553; JC5553.
DR   RefSeq; NP_071852.2; NM_022407.3.
DR   AlphaFoldDB; P51647; -.
DR   SMR; P51647; -.
DR   STRING; 10116.ENSRNOP00000024000; -.
DR   BindingDB; P51647; -.
DR   ChEMBL; CHEMBL2931; -.
DR   SwissLipids; SLP:000000800; -.
DR   GlyGen; P51647; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P51647; -.
DR   PhosphoSitePlus; P51647; -.
DR   SwissPalm; P51647; -.
DR   jPOST; P51647; -.
DR   PaxDb; 10116-ENSRNOP00000024000; -.
DR   GeneID; 24188; -.
DR   KEGG; rno:24188; -.
DR   UCSC; RGD:2087; rat.
DR   AGR; RGD:2087; -.
DR   CTD; 216; -.
DR   RGD; 2087; Aldh1a1.
DR   eggNOG; KOG2450; Eukaryota.
DR   HOGENOM; CLU_005391_0_2_1; -.
DR   InParanoid; P51647; -.
DR   OrthoDB; 2291791at2759; -.
DR   PhylomeDB; P51647; -.
DR   TreeFam; TF300455; -.
DR   BRENDA; 1.2.1.36; 5301.
DR   Reactome; R-RNO-5365859; RA biosynthesis pathway.
DR   Reactome; R-RNO-70350; Fructose catabolism.
DR   Reactome; R-RNO-71384; Ethanol oxidation.
DR   SABIO-RK; P51647; -.
DR   UniPathway; UPA00912; -.
DR   PRO; PR:P51647; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; ISO:RGD.
DR   GO; GO:0106373; F:3-deoxyglucosone dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; IDA:RGD.
DR   GO; GO:0019145; F:aminobutyraldehyde dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0018479; F:benzaldehyde dehydrogenase (NAD+) activity; IDA:RGD.
DR   GO; GO:0043878; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; IEA:RHEA.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0051287; F:NAD binding; ISS:CAFA.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0042904; P:9-cis-retinoic acid biosynthetic process; ISO:RGD.
DR   GO; GO:0042905; P:9-cis-retinoic acid metabolic process; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0110095; P:cellular detoxification of aldehyde; IMP:UniProtKB.
DR   GO; GO:0048048; P:embryonic eye morphogenesis; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0030392; P:fructosamine catabolic process; ISS:UniProtKB.
DR   GO; GO:0006001; P:fructose catabolic process; ISO:RGD.
DR   GO; GO:0009449; P:gamma-aminobutyric acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0036438; P:maintenance of lens transparency; IMP:UniProtKB.
DR   GO; GO:0007494; P:midgut development; IEP:RGD.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0002072; P:optic cup morphogenesis involved in camera-type eye development; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0002138; P:retinoic acid biosynthetic process; IMP:RGD.
DR   GO; GO:0042573; P:retinoic acid metabolic process; ISO:RGD.
DR   GO; GO:0001523; P:retinoid metabolic process; IDA:UniProtKB.
DR   GO; GO:0042572; P:retinol metabolic process; ISO:RGD.
DR   CDD; cd07141; ALDH_F1AB_F2_RALDH1; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   PANTHER; PTHR11699:SF140; ALDEHYDE DEHYDROGENASE 1A1; 1.
DR   PANTHER; PTHR11699; ALDEHYDE DEHYDROGENASE-RELATED; 1.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; ALDH-like; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell projection; Cytoplasm; Direct protein sequencing;
KW   Lipid metabolism; NAD; Oxidoreductase; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P15437,
FT                   ECO:0000269|PubMed:7832787"
FT   CHAIN           2..501
FT                   /note="Aldehyde dehydrogenase 1A1"
FT                   /id="PRO_0000056419"
FT   REGION          336..501
FT                   /note="Mediates interaction with PRMT3"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   ACT_SITE        269
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10007,
FT                   ECO:0000255|PROSITE-ProRule:PRU10008"
FT   ACT_SITE        303
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10007,
FT                   ECO:0000255|PROSITE-ProRule:PRU10008"
FT   BINDING         167..170
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         193..196
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         226..227
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         246..247
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         269..271
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         349..353
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   BINDING         400..402
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   SITE            170
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P20000"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15437"
FT   MOD_RES         91
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         128
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         337
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         353
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         367
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         410
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         419
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         435
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   MOD_RES         495
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   CONFLICT        100
FT                   /note="R -> C (in Ref. 1; AAA96657)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="I -> M (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        170
FT                   /note="N -> E (in Ref. 1; AAA96657)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   501 AA;  54459 MW;  A3614C21BCE7E144 CRC64;
     MSSPAQPAVP APLANLKIQH TKIFINNEWH DSVSGKKFPV LNPATEEVIC HVEEGDKADV
     DKAVKAARQA FQIGSPWRTM DASERGRLLN KLADLMERDR LLLATIEAIN GGKVFANAYL
     SDLGGSIKAL KYCAGWADKI HGQTIPSDGD IFTFTRREPI GVCGQIIPWN FPLLMFIWKI
     GPALSCGNTV VVKPAEQTPL TALHMASLIK EAGFPPGVVN IVPGYGPTAG AAISSHMDVD
     KVAFTGSTQV GKLIKEAAGK SNLKRVTLEL GGKSPCIVFA DADLDIAVEF AHHGVFYHQG
     QCCVAASRIF VEESVYDEFV RKSVERAKKY VLGNPLTQGI NQGPQIDKEQ HDKILDLIES
     GKKEGAKLEC GGGRWGNKGF FVQPTVFSNV TDEMRIAKEE IFGPVQQIMK FKSIDDVIKR
     ANNTTYGLAA GVFTKDLDRA ITVSSALQAG VVWVNCYMIL SAQCPFGGFK MSGNGRELGE
     HGLYEYTELK TVAMKISQKN S
//
